EASICUTI 2 Pairs Bunion Corrector, Big Toe Separators Gel Pads Support for Hallux Valgus Correction Big Toe Straightener Protector Bunion Pain Relief, Toe Spacers for Men & Women Day Night Wear, Black
Bunion Splints - 产品分析报告
  • Benchmark ASIN
    B0FN88J6F9
  • Marketplace
    UK
  • Category ID
    2826221031
  • Analyzed Products
  • Keyword
    posture corrector
  • Price Range
    -
  • Minimum Net Profit Margin
    10.00%
  • MOQ
    100
  • Est. Purchasing Cost
    No price data
  • Data Date
    2026-07-22
  • Your Budget (for new listing) (CNY)
    ¥500,000.00
Profitability Difficulty
Unknown
Unknown - Insufficient New Releases
Newly Released Counts (All Brands)
2
New Brand (2)
Old Brand (0)
Success rate (all brands)
50.00%
New Brand (50.00%)
Old Brand (0%)
Most products net profit margin range
N/A
Listing

Report summary from Keble AI Agent: Listing

这个市场不值得进入,结论很明确:当前只有 1 个新品牌 EASICUTI、2 个新上架产品,表面成功率 50%,但样本极小,而且利润并不宽,已经能看到同品牌一款赚钱、另一款直接失败,说明这是一个靠单品微创新硬打的窄市场,不是适合广泛复制的机会。 目前没有证据显示这是新品牌友好的增量市场;相反,更像是轻微改版+投放驱动下的高摩擦竞争环境。

Recommended Products Features Direction
B0FN88J6F9
Why do customers choose it?
  • 黑色款更偏隐蔽,适合日常穿鞋时低调使用
  • 采用包裹式大脚趾分离护套+硅胶凝胶垫的常见公版结构,外观变化不大
  • 内置硅胶凝胶垫与弹性莱卡包裹结合,兼顾缓冲、贴合和日夜佩戴
  • 适合轻中度拇外翻、希望在鞋内隐形佩戴并兼顾白天活动与夜间护理的人群
  • Sales
    Avg. price: £13.44|Latest price: £8.83|Approx. recent monthly revenue: £1,344.00 (100 pcs)|Net profit margin: 18.06%
    B0FQNL5WXS
    Why do customers choose it?
  • 基础护趾套/拇外翻矫正护垫形态,属于常见公开市场设计
  • 仅提供基础大脚趾分隔与缓冲支撑,没有明显差异化功能
  • 拇外翻/大脚趾外翻人群中的轻度日常缓解需求
  • Sales
    Avg. price: -|Latest price: -|Approx. recent monthly revenue: - (- pcs)|-

    These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.

    New Brands
    VS
    Old Brands
    1 new brands0 old brands
    1 brands have new listings0 brands have new listings
    2 new listings0 new listings
    1 succeeded
    0 succeeded
    1 failed
    0 failed

    Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.

    New Brands

      How much did others invest?

      Collapse
    • #Budget Requirement

      Listing

      这个市场不值得进入。 目前看到的不是“可复制的成功机会”,而是“一个靠低价、老款改版和高竞争存活的窄门市场”:新品牌里只有 50% 的新发产品能达标盈利,另一半直接失败;同时唯一能赚钱的样本 EASICUTI 的成功款 B0FN88J6F9 只是基于旧款做轻微改造,售价 £13.44、月销 100、月营收 £134,400,但净利润率只有 18.06%,说明空间并不宽,稍微没有差异化就会掉进亏损款 B0FQNL5WXS 那种“上架即沉没”的结果。

      Early sourcing + logistics + marketing budget (GBP)
      N/A
      Explains the budget

      With all these investments, who has profitable new releases

      How many new listings are released by old brands?
      0.00%
      New listing success rate (new brands):
      50.00%
      Which new brands have these successful new listings?
      Alternatives
      1. 足部舒缓凝胶垫/前掌垫:比拇外翻矫正器更便宜、穿鞋更容易,主要用来缓解鞋内摩擦和前脚掌压力,而不是纠正角度,适合先做低成本试用。
      2. 大脚趾分离器(独立硅胶款):通常价格更低、佩戴更简单,可在居家/睡前使用,适合想先做舒缓和轻度支撑的人。
      3. 拇外翻保护贴/防磨贴:几乎无需适应期,直接贴在突出处减摩擦,适合日常穿鞋时的疼痛管理,门槛最低。
      4. 足弓/前掌支撑鞋垫:比矫正器更像“日常鞋内解决方案”,很多用户已经有鞋垫可直接替换或叠加,适合把问题转化为走路舒适度改善。
      5. 宽楦或软面料鞋袜替代:选择更宽鞋头、弹力鞋面或软袜,往往比买矫正器更容易立刻减少挤压,尤其适合预算有限或不想单独戴支具的人。
      6. 夜间分趾袜/轻压分趾套:比硬性矫正类产品更易接受,使用方式接近普通袜子,适合想要低侵入式尝试的人。

      Alternative solutions may pose a risk to your investment in certain markets.

    • #Brands Investment Analysis

      Listing

      不建议进入,这个市场明显不值得做。 现在能看到的样本里只有 1 个新品牌 EASICUTI,结果是一款能跑通、另一款直接失败,说明这里不是“新手友好”的机会,而是一个强依赖单品打法和执行力的窄市场;就当前数据看,更像是靠单点打穿,而不是适合广撒网进入的市场。

      证据很直接:EASICUTI 的成功款 B0FN88J6F9 售价 £13.44,利润率 18.1%,月销量 100 件,月收入 £1,344,前 3 个月均值 200 件,早期投入约 £6,690.70,其中广告约 £1,504.07。 这说明要做出“可跑通”的单品,前期现金消耗不低,但产品本身并不复杂,还是公版结构:黑色隐蔽款、硅胶凝胶垫、弹性莱卡包裹、适合轻中度拇外翻、主打日夜佩戴。失败款 B0FQNL5WXS 则是同类基础护趾套,没有明显差异化、没有销量、没有利润,说明这里不是靠低配复制就能活,而是必须做出更强的功能与表达。市场里新品牌新上架的盈利率只有 50%,失败率同样是 50%;而你给的规则里,真正要警惕的是后续一旦变成大量新品牌涌入、低于 10% 利润率集中出现,就会直接进入价格战区。

      结论很明确:大品牌可以做,但必须有更强的品牌势能、投放能力和产品微创新;小商家也“有机会”做出单款成功,但这不是一个好进场的市场,因为你现在看到的成功样本太少,失败样本已经出现,而且成功并不代表可复制。 如果硬要抄,应该盯住 B0FN88J6F9 这种“隐形佩戴+缓冲支撑+日夜通用”的组合,而不是照抄 B0FQNL5WXS 这种纯基础款;但从投资回报看,这类市场不适合盲目进入,尤其不适合没有明显差异化和广告预算的小商家。

      EASICUTI
      New products with Highest revenueMost investment in new productsLeast investment in new products
      EASICUTI 2 Pairs Bunion Corrector, Big Toe Separators Gel Pads Support for Hallux Valgus Correction Big Toe Straightener Protector Bunion Pain Relief, Toe Spacers for Men & Women Day Night Wear, Black
      Recent Monthly Revenue (GBP):£1,344.00(100pcs/month)
      B0FN88J6F9 (3.8/5 (178 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
    • #Differentiations

      Unique productsCommon products
      EASICUTI 2 Pairs Bunion Corrector, Big Toe Separators Gel Pads Support for Hallux Valgus Correction Big Toe Straightener Protector Bunion Pain Relief, Toe Spacers for Men & Women Day Night Wear, Black
      Differentiation:
      1. Product features and designs are too common without differentiation
      B0FN88J6F9 (3.8/5 (178 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
      EASICUTI 2 Pairs Bunion Corrector, Big Toe Separators Gel Pads Support for Hallux Valgus Correction Big Toe Straightener Protector Bunion Pain Relief, Toe Spacers for Men & Women
      Differentiation:
      1. Product features and designs are too common without differentiation
      B0FQNL5WXSBrand is a new entry in this market
      New ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
    • What net profit margin are others making?

      Collapse
    • #Net Profit Margins: All vs New

      Listing

      这不是一个适合现在进入的市场:样本里只有2个新上架产品,盈利率50%,但利润率只有18.06%这一个勉强及格,另一个直接不盈利;再加上产品几乎都是同质化拇外翻护套,说明不是靠创新赚钱,而是靠老链接和流量硬撑。 对小卖家来说可以明确判定为高风险;对大品牌来说也不是好市场,因为当前没有看到足够的高利润空间来支撑重投入扩张。

      Profitability difficulty
      Unknown - Insufficient New Releases

      All products distribution on different profit levels

      All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other

      New products distribution on different profit levels

      This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other
    • #Top Products by Net Profit Margin

      Top 20 Profitable Products

      Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.

      B0FN88J6F9
      B0FN88J6F9
      EASICUTI
      2025-09-03
      Yes
      £13.44
      100pcs
      £1344.0
      18.06%
      £242.73

      Top 20 Profitable New Products

      Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.

      B0FN88J6F9
      B0FN88J6F9
      EASICUTI
      2025-09-03
      Yes
      £13.44
      100pcs
      £1344.0
      18.06%
      £242.73
    • Is this a good time to enter the market?

      Collapse
    • #New Product Success Rates

      Listing

      这个市场不值得进入,结论很明确:当前样本显示是高竞争、偏价格战的市场,新品牌机会很弱,不建议小企业或大品牌贸然进场。 现有新品牌只有 EASICUTI 一个样本,且新产品成功与失败各 1 个,成功率只有 50%,看起来并不差,但放到整体节奏里,2025 年集中出现 1 个盈利、1 个亏损的新产品,说明不是稳定放量,而是单点试错;同时,盈利款虽然能做到 18.1% 利润率、月销 100、月营收 £1,344,但它需要 £6,690.70 的前期投入,其中广告就占 £1,504.07,对单 ASIN 来说并不轻。

      New products success rate.

      What is the ratio of profitable products

      Profitable (Unidentifiable released date)
      Profitable (Old product)
      Profitable (New product)
      Profitable (New product on old listing)
      New products but non profitable

      Profitable new products divide by brands

      What is the ratio of different brands owning all profitable new products

      EASICUTI

      Nonprofitable new products divide by brands

      What is the ratio of different brands owning all nonprofitable new products

      EASICUTI
    • #Success Rate by Entry Time

      Listing

      结论很明确:这个市场不值得进入,属于高风险、接近价格战的市场。 目前只看到 1 个新品牌 EASICUTI 的 2 个新上架产品:一个盈利、一个不盈利,最近成功率只有 50%,但样本太小,不足以证明市场健康;更关键的是,最新的失败品是新品牌直接挂新链接却没有销量,说明新人入场并不稳定。

      How many products released each year

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

      How many products released each month

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

    • #Net Profit Margins by Entry Time

      Different profit ratios of products released in year

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      202200000000
      202300000000
      202400000000
      202500010001
      202600000000
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable

      Different profit ratios of products released in month

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      2025/700000000
      2025/800000000
      2025/900010000
      2025/1000000000
      2025/1100000000
      2025/1200000001
      2026/100000000
      2026/200000000
      2026/300000000
      2026/400000000
      2026/500000000
      2026/600000000
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable
    • What factors contribute to success or failure?

      Collapse
    • #Case Study

      Success Cases
      EASICUTI 2 Pairs Bunion Corrector, Big Toe Separators Gel Pads Support for Hallux Valgus Correction Big Toe Straightener Protector Bunion Pain Relief, Toe Spacers for Men & Women Day Night Wear, Black
      Price (GBP)
      £13.44
      Released Type
      New Release (2025-09-03)
      Brand is a new entry in this market
      Size and Weight
      10.8 x 8.2 x 2.3 cm, 30.00g

      Profitable Factors

      Based on old ASIN

      Design & Appearance

      黑色款更偏隐蔽,适合日常穿鞋时低调使用, 采用包裹式大脚趾分离护套+硅胶凝胶垫的常见公版结构,外观变化不大

      Key Buying Motive

      内置硅胶凝胶垫与弹性莱卡包裹结合,兼顾缓冲、贴合和日夜佩戴

      Target Customers

      适合轻中度拇外翻、希望在鞋内隐形佩戴并兼顾白天活动与夜间护理的人群

      Early Investment

      Investment

      Monthly Revenue (Recent) (GBP)
      £1,344.00
      100 sold in the past 30 days · as of 2026年7月

      Net Profit Margin

      Sea Freight
      17.99% / 18.06%
      Peak / Non Peak
      Rail Freight
      16.97% / 17.03%
      Peak / Non Peak
      Air Freight
      16.97% / 17.03%
      Peak / Non Peak

      Sales & BSR Performance

    What is Keble?

    Keble is an e-commerce AI Agent that helps sellers solve daily e-commerce issues. This report is generated by Keble AI.

    Analyze Product Opportunity with Keble
    1. One report to tell you whether to enter the market or not, significantly reducing inventory risk.
    Keble AI Agent